RD-Biotech is a French CRO that proposed services in biotechnology:
Bioproduction: mAb, recombinant proteins, plasmids
Research contracts: cell line, hybridoma development, cloning, humanization, ELISA
Biotech Investissement, majority shareholder of RD-BIOTECH, acquired Diaclone SAS on 2012: a wide range of mAbs & Immunoassays
SynAbs, a Belgium company. Joined the Group last month. Its expertise in rat mAb greatly complement the expertise of the sister companies in the field of mAbs